Article

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

Diabetes Research Institute, University of Düsseldorf, Germany.
Diabetologia (Impact Factor: 6.88). 08/1998; 41(8):891-7. DOI: 10.1007/s001250051004
Source: PubMed

ABSTRACT Type I diabetes mellitus may represent a heterogeneous disorder with a distinct pathogenesis in patients with young and adult onset of the disease. To investigate whether serological markers directed to different autoantigens have the potential to distinguish acute onset from slowly progressive Type I diabetes we analysed antibodies to tyrosine phosphatases IA-2/ICA512 (IA-2A) and IA-2beta/phogrin (IA2betaA), antibodies to GAD65 (GADA) and cytoplasmic islet cell antibodies (ICA) in a non-selected group of diabetic patients clinically classified as having Type I or Type II diabetes at diagnosis. Both IA-2A and IA-2betaBA were found to be positively associated with onset before the age of 20 years and the presentation of classical features of Type I diabetes. In Type I diabetes 56 % (112/200) of patients were positive for IA-2A and 38 % (76/200) for IA-2betaA. In contrast, only 1 of 785 (0.1 %) patients with Type II diabetes had IA-2A and all of them were negative for IA-2betaA (p < 0.001). Among the patients with Type II diabetes 7.6% (n = 60) were ICA positive and 2.8% (n = 22) had GADA suggesting the presence of slowly progressive Type I diabetes. GADA were found in 8 of 60 (13.3 %) ICA positive subjects which was lower than the percentage detected in patients with acute onset of diabetes (115/157 73.2%) (p < 0.001). Blocking of double antibody positive sera showed that only 3 of 8 (37.5 %) patients with slowly progressive diabetes had ICA restricted to GAD or IA-2 whereas ICA were completely inhibited in 12 of 20 (60.0 %) patients with Type I diabetes. Among 193 patients with Type II diabetes available for follow-up, 35 % of ICA positives, 58 % of GADA positives and 60 % of those positive for both markers required insulin by 3 years. However, using strict criteria for the switch to insulin treatment the corresponding sensitivity of each marker was only low (9%, 10% and 5%). We show that clinical subtypes of Type I diabetes are associated with distinct humoral autoimmunity. IA-2A and GADA were associated with classical features of Type I diabetes whereas GADA and an uncharacterized ICA subspecificity indicate slowly progressive disease.

0 Followers
 · 
61 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cytotoxic T lymphocyte-associated antigen 4 gene (CTLA-4) encode the T cell receptor involved in the control of T cell proliferation and mediates T cell apoptosis. The receptor protein is a specific T lymphocyte surface antigen that is detected on cells only after antigen presentation. Thus, CTLA-4 is directly involved in both immune and autoimmune responses and may be involved in the pathogenesis of multiple T cell-mediated autoimmune disorders. There is polymorphism at position 49 in exon 1 of the CTLA-4 gene, providing an A-G exchange. Moreover, we assessed the CTLA-4 49 (Thr/Ala) polymorphism in diabetic patients and first-degree relatives as compared to control subjects. Three loci (HLA-DQB1, DQA1 and CTLA-4) were analysed in 62 type 1 diabetic patients, 72 first-degree relatives and 84 nondiabetic control subjects by means of PCR-RFLP. A significant enrichment in DQB1 alleles encoding for an amino acid different from Asp in position 57 (NA) and DQA1 alleles encoding for Arg in position 52 was observed in diabetic subjects and first-degree relatives as compared to controls. The genotype and allele frequencies of these polymorphisms in type 1 diabetic patients and first-degree relatives differed significantly from those of controls (p < 0.001 and 0.05 respectively). CTLA-49 Ala alleles frequencies were 75.8% in type 1 diabetic patients and 68.1% in first-degree relatives in comparison to 35.7% in control subjects. The Ala/Ala genotype conferred a relative risk of 18.8 (p < 0.001). The CTLA-4 49 Ala allele confers an increased risk of type 1 diabetes, independent of age and HLA-DQ genetic markers.
    International Journal of Experimental Diabetes Research 02/2002; 3(1):1-9. DOI:10.1080/15604280212527
  • [Show abstract] [Hide abstract]
    ABSTRACT: Islet cell antibodies (ICA) represent a heterogenous group of autoantibodies to diabetes-associated antigens, including glutamic acid decarboxylase (GAD) and the IA-2 protein. The objectives of the present study were to compare the prevalence of autoantibodies to known biochemically characterized autoantigens between ICA-positive non-diabetic parents and siblings of children with type 1 diabetes and to evaluate how such antibodies explain ICA reactivity. The presence and levels of GAD antibodies (GADA), IA-2 antibodies (IA-2A) and insulin autoantibodies (IAA) were analyzed in the sera of 184 ICA-positive first-degree relatives (79 parents and 105 siblings). The prevalences of GADA (61.9% in siblings vs 32.9% in parents), IA-2A (55.2% vs 15.2%) and IAA (41.0% vs 0%) were increased among ICA-positive siblings relative to ICA-positive parents (p<0.001). The siblings had higher ICA titers (p<0.001) than the parents but tended to have lower GADA levels (p=0.12). IA-2A levels did not differ between the two groups. IA-2A levels explained a higher proportion of the ICA reactivity in the siblings than in the parents (44% vs 12%, p=0.004), and GADA levels had the same tendency (27% vs 10%, p=0.11). In a multiple regression analysis, GADA and IA-2A were found to explain together 16% of the ICA reactivity in parents and 49% in siblings (p=0.003 for the difference). These results indicate that the increased frequency of additional diabetes-associated autoantibodies in ICA-positive siblings when compared to their ICA-positive parents may reflect the increased risk of progression to clinical type 1 diabetes previously reported in young ICA-positive relatives. We conclude that ICA immunofluorescence is not only due to GADA and IA-2A, but there are other additional antigens contributing to the ICA reactivity. Antibodies to such antigens appear to be more common among adults than in children.
    Diabetes/Metabolism Research and Reviews 18(1):43-8. · 2.97 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Der Diabetes mellitus Typ 1 (T1D) ist eine Autoimmunerkrankung, bei der es zu einer Zerstörung der insulinproduzierenden ß-Zellen des Pankreas kommt. Diese Erkrankung zeigt eine hohe Variabilität im Zeitpunkt der klinischen Manifestation der Erkrankung. Der Symptombeginn reicht von der frühen Kindheit bis in das höhere Alter. Hinsichtlich des Manifestationsalters und auch genetischer, immunologischer und klinischer Aspekte unterteilt man den T1D in drei Subklassen: den T1D mit Manifestation im Kindesalter, den T1D mit Manifestation im Erwachsenenalter und den Latent Autoimmune Diabetes in Adults (LADA). Es stellt sich die Frage, warum diese T1D-Subklassen unterschiedlich lange Phasen der Latenz aufweisen. Man vermutet, dass der juvenile T1D durch eine Th1-Zell-dominierte Immunantwort geprägt ist, wogegen bei den T1D-Klassen, die erst im Erwachsenenalter ihre Manifestation zeigen, eine weniger aggressive Th2-Antwort vorherrscht. Um dieser Hypothese nachzugehen, wurden in der Arbeit immunologische Marker im peripheren Serum von "jungen" bis "alten" T1D-Patienten bestimmt. Mittels eines Enzyme Linked ImmunoSorbant Assay wurden die Subklassen der Autoantikörper gegen Glutamatdecarboxylase 65, einem Hauptautoantigen des T1D, bestimmt. Zusätzlich wurden 17 humane Zytokine (Interleukine 1ß, 2, 4, 5, 6, 7, 8, 10, 12, 13, 17, TNF-alpha, INF-gamma, GM-CSF, G-CSF, MCP-1 und MIP-1ß) durch einen Fluoreszenz-ELISA detektiert. Insgesamt konnten in dieser Arbeit keine immunologisch basierten Ursachen für die variablen Latenzphasen der T1D-Subklassen gefunden werden. Die Ergebnisse weisen darauf hin, dass alle Subklassen des T1D durch sehr ähnliche immunologische Prozesse geprägt sind, wobei sowohl das angeborene als auch das erworbene, adaptive Immunsystem involviert sind. Unterschiede im Zytokinmuster bzw. im GAD65-Antikörper-Level in Abhängigkeit vom Alter der T1D-Manifestation konnten weder widerlegt noch bestätigt werden.

Preview

Download
2 Downloads
Available from